Neurosarcoidosis and infliximab therapy monitored by 18FDG PET/CT

Learning points for cliniciansNeurosarcoidosis is a severe disease affecting young adults with a mortality rate of 5%.Cranial nerve palsy, spinal cord disease, seizures or headaches are the main symptoms.18FDG PET/CT is useful in diagnosing neurosarcoidosis involving cranial nerves and in monitoring treatment response under tumor necrosis factor-alpha inhibitors, such as infliximab.
Source: QJM - Category: Internal Medicine Source Type: research